Business context and reporting period
This summary reflects the Form 10-Q filed November 14, 2018, for the quarter ended September 30, 2018. The filing identifies the registrant as Information Analysis Incorporated (IAI), a Virginia-based provider of IT modernization, software, and professional services, with significant federal-government exposure. This does not match the requested company name, Firefly Neuroscience, Inc.; verify the filing identity before relying on this summary.
Financial performance and position
| Metric | Q3 2018 | Q3 2017 | Nine months 2018 | Nine months 2017 |
|---|---|---|---|---|
| Revenue | $2.419 million | $2.732 million | $7.521 million | $8.270 million |
| Gross profit (margin) | $569,106 (23.5%) | $635,891 (23.3%) | $1.675 million (22.3%) | $1.773 million (21.4%) |
| Operating income (loss) | $25,090 | $107,999 | ($19,724) | $160,946 |
| Net income (loss) | $27,964 | $110,284 | ($11,194) | $167,386 |
| Operating cash flow | Not separately stated for the quarter | ($675,463) | $655,206 |
- Cash and cash equivalents were $2.054 million at September 30, 2018, down from $2.732 million at December 31, 2017. Total current assets were $3.685 million and current liabilities $1.792 million.
- No borrowings were outstanding under the $1.0 million revolving credit facility, which expires May 31, 2020. The filing reports no material capital-expenditure commitments or off-balance-sheet arrangements.
- Revenue was primarily from professional fees and software sales. In Q3, federal prime contracts contributed 71.3% of revenue, federal subcontracts 24.7%, and commercial contracts 4.0%.
Changes versus comparable periods
- Q3 revenue fell 11.5% year over year; professional-fee revenue declined 19.8% and software revenue 2.9%. Management attributed the professional-fee decline mainly to completed or expired contracts and changing activity on continuing contracts.
- For the first nine months, revenue fell 9.1%; professional fees declined 6.7% and software sales 10.9%. Gross margin improved to 22.3% from 21.4%, but the company moved from prior-year operating and net income to small losses.
- Nine-month SG&A excluding commissions rose 7.1%, attributed to non-billable labor and benefits, stock-option costs, ISO certification, bids and proposals, and severance. Q3 SG&A rose 5.9%.
- Q3 net income margin was 1.2%, versus 4.0% a year earlier; nine-month net margin was (0.1%), versus 2.0%.
Outlook, risks, and notable items
- Management said current cash and its operating plan should meet cash requirements for at least 12 months from the filing date. No specific revenue or earnings guidance was provided.
- Operating cash use was driven in part by a $549,083 increase in accounts receivable and contract assets. Receivables were concentrated: one federal subcontract represented 42.5% of outstanding receivables at quarter-end.
- A single major software supplier accounted for 51.1% of Q3 revenue and 53.5% of nine-month revenue. Management noted software sales and margins can fluctuate substantially with product mix and referral fees.
- Risks cited include federal funding and contracting changes, competition, technology shifts, contract-cost and timing estimates, subcontractor or supplier performance, and dependence on third-party software suppliers. The filing reported no material changes to the risk factors in the 2017 Form 10-K and no legal proceedings.
- The company adopted ASC 606 in 2018; management said adoption had no material impact. Federal net operating loss carryforwards were $14,959,541, including $7,750,305 that would expire if unused on December 31, 2018.
- Disclosure controls were assessed as effective, and no material change in internal control over financial reporting was reported. The filing presents 2018 per-share amounts as a dash rather than a clear numeric EPS value.
Important facts to verify
- Confirm that this Information Analysis Incorporated filing—not a Firefly Neuroscience filing—is the intended document.
- Review the receivables concentration and subsequent collections, particularly the federal subcontract balance.
- Assess the effects of the major software supplier and federal-contract/customer concentration on revenue continuity.
- Check cash-flow trends and management’s stated 12-month liquidity outlook against subsequent results.
- Verify the status and utilization of the NOL carryforwards, including the amount identified as expiring at year-end 2018.